Virdante Pharmaceuticals completes venture financing

Virdante Pharmaceuticals Inc., Cambridge, Mass. Business: Autoimmune, Inflammation Date completed: 10/29/09 Type: Venture financing Raised: $47.8 million Investors: Clarus Ventures; Venrock; Thomas, M...